Fierce Pharma

GSK licenses Alteogen enzyme in bid to develop subQ Jemperli

With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...

FDA approves first treatment for Menkes disease in children

The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
Neurology Advisor

First Treatment for Menkes Disease: FDA Approves Copper Histidinate

The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.
Oncology Nurse Advisor

FDA Approves Subcutaneous Rybrevant Faspro for EGFR-Mutated Non-Small Cell Lung Cancer

Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.
AZoLifeSciences on MSN

Engineered human skin acts as a living biosensor for inflammation

Implanted living skin-based biosensors offer a breakthrough in inflammation tracking, providing real-time biomarker ...
Everyday Health on MSN

How to plan for successful home SCIg self-administration for primary immunodeficiency

Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing ...
BMJ Case Reports

Use of endotracheal epinephrine for refractory unanticipated post-intubation bronchospasm

Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...